Loading...
BYH: To the Confederates of the civil war. Today if they were in power there would be no race problems, or issues today....

Welcome competition should lower EpiPen prices

CVS-EpiPen Generic

A rival generic version of Mylan's EpiPen has been approved for sale at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers.

Loading…

Friday, August 24, 2018

A couple of years ago Washington fell into anaphylactic shock over the high cost of EpiPens, devices that shoot adrenaline into someone having an allergic reaction. But the Trump Administration this week injected some overdue competition into the market that could lower prices for millions of Americans.

On Thursday the Food and Drug Administration approved the first generic competitor to Mylan ‘s EpiPen. The competing drug is manufactured by the Israeli pharmaceutical company Teva. One might wonder why a simple spring device filled with a cheap medicine didn’t have competitors, even decades after invention.

That was one question in 2016, when Congress hauled in Mylan CEO Heather Bresch to register outrage about the more than $600 list price of a two-pack of pens, which millions of kids and adults have to keep on hand. Not everyone pays full price after rebates and discounts, and some of the shock came from insurance designs that increased out-of-pocket costs. But the sticker price had increased more than 500 percent over 10 years.

Yet if Mylan kept prices high, the company had help from the FDA. The agency had not articulated standards for a class of drugs known as “complex generics” such as inhalers, which are more fraught than proving similarity to, say, a molecule pill. Mylan thus had no direct competition, though it now sells its own generic copy.

Other injectors are on the market but a pharmacist can’t substitute these versions thanks to issues as minor as the instructions for the device, though there is no clinical distinction. Companies like Teva have spent years ensnared in FDA processes, and in the meantime Mylan could increase prices without market consequences.

Before he became the current FDA Commissioner, Scott Gottlieb told Congress in 2016 about the “Catch-22” for drugmakers: They couldn’t win approval as a generic because another injection device wasn’t exactly the same as EpiPen, but other regulations also make it hard for competitors to get branded alternatives through the FDA’s new drug approval pathway.

Dr. Gottlieb has made clarity for such complex generics a priority at the FDA, and on Thursday he called the Teva device approval part of the agency’s efforts to remove barriers to competition. The approval is particularly timely amid supply shortages of EpiPens.

On all the evidence, products face the sharpest price decline when two generics are competing with the branded version. More drugmakers will jump into a market if they see an opportunity to make money and a regulatory agency that doesn’t construct needless barriers to entry.

At the time of the EpiPen brouhaha, Hillary Clinton called for a federal “consumer response team” that would rove around and penalize companies for price spikes. The laugh-cry moment is that the Trump Administration has flirted with a response from the Clinton playbook: Importing price controls from Europe for drugs with expired patents that lack competition.

President Trump seems to think that drugs are too expensive because of unfettered markets, but the EpiPen episode is a reminder: The real culprit is often not too much freedom but big business exploiting big government to keep prices high.

The Wall Street Journal

Loading…

Humans of Greenville

@HumansofGville

Local photographer Joe Pellegrino explores Greenville to create a photographic census of its people.

Editorials

January 24, 2019

Rep. George Holding and Sen. Thom Tillis say they want to work themselves out of a job.

The Republican pair sponsored legislation last week proposing a constitutional amendment that would limit lawmakers to two six-year Senate terms or six two-year terms in the House of Representatives.…

Election 202 Senate Races-1

January 23, 2019

Caught repeatedly in the exaggeration that thousands of terrorists enter the United States by illegally crossing the Mexican border, President Trump has returned to making another debunked assertion: Undocumented immigrants are stealing jobs from people born in this country.

It isn’t true,…

Miami Science Museum-2

January 22, 2019

The day to celebrate Martin Luther King Jr.’s life seems an appropriate moment to update the progress observed along the long road to racial equality while recognizing acts of courage seen in the spirit of King’s life. One such example came just last week on the campus of UNC-Chapel…

Confederate Monument-Protest

January 22, 2019

North Carolina’s highest court will soon decide whether defendants who believe they were wrongfully convicted have the right to complain to the jurors who sat in judgment.

A three-judge N.C. Court of Appeals panel upheld the state’s problematically vague juror harassment law in a 2-1…

2016FactbookXXX

January 18, 2019

For lawmakers looking for a way to end the longest government shutdown in history, we have a suggestion. Google the 13th Amendment and read what it says. It’s just one sentence.

“Neither slavery nor involuntary servitude, except as a punishment for crime whereof the party shall have…

eleanorclift.jpg

January 18, 2019

What is among the most nagging, gear-grinding frustrations generated by the Great Government Shutdown is that the folks in Washington will do nothing about it except whine.

The shutdown will enter its 28th day today. Apparently, the impasse is over funding to build for a wall between Mexico and the…

Government Shutdown-3

January 17, 2019

UNC-Chapel Hill Chancellor Carol Folt has displayed patience and grace in navigating the various pressures from the UNC System Board of Governors and the leadership of the General Assembly. It has been particularly evident in addressing the controversy over the fate of the “Silent Sam”…

Confederate Monuments North Carolina

January 16, 2019

Two weeks into this new session of Congress and we’re no closer to knowing who will represent North Carolina’s 9th District in the House of Representatives. Nor do we know who will make the final call on how the seat will be filled or who will fill it. Will it be the state’s board…

Election 2018 9th Congressional District-2

January 14, 2019

Since 1990, lions, tigers and other big cats have killed 24 people ... in the United States.

The latest fatality occurred one week ago near Burlington, when a captive lion attacked and killed an intern at a wildlife center.

Alexandra Black, 22, who had been on the job for only two weeks, was…

Lion Attack-1

January 13, 2019

How fitting is it that President Trump’s first Oval Office address was aimed at stirring up the American public about a crisis largely of his own making?

Pursuing poorly thought-out and even more poorly executed policies on the pretext of battling a nonexistent national security crisis, Trump…

Government Shutdown Trump
87 stories in Editorials. Viewing 1 through 10.
«First Page   «Previous Page        
Page 1 of 9
        Next Page»   Last Page»